◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › 0-9 › 3759

Pharmaron Beijing Co., Ltd. (3759) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-08-10

Pharmaron Beijing Co., Ltd. (3759) operates in the Biotechnology industry and is headquartered in Beijing, China with about 25,088 employees. Its market capitalization is roughly CNY 50 billion. In the fiscal year ended 2025-12-31, 3759 reported CNY 14.1B in revenue and CNY 1.7B in net income.

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally.

Interactive charts & full statements →

3759 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 14.1BCNY 12.3BCNY 11.5BCNY 10.3B—
Gross ProfitCNY 4.9BCNY 4.2BCNY 4.1BCNY 3.8B—
Operating Income (EBIT)CNY 2.2BCNY 1.9BCNY 1.8BCNY 1.8B—
Net IncomeCNY 1.7BCNY 1.8BCNY 1.6BCNY 1.4B—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3759 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total RevenueCNY 3.6BCNY 4.0B—CNY 3.3BCNY 3.1BCNY 3.5B
Gross ProfitCNY 1.2BCNY 1.5B—CNY 1.1BCNY 1.0BCNY 1.2B
Operating Income (EBIT)CNY 496MCNY 713M—CNY 526MCNY 446MCNY 645M
Net IncomeCNY 335MCNY 523M—CNY 396MCNY 306MCNY 372M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3759 Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(CNY 531M)(CNY 542M)(CNY 445M)(CNY 405M)—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3759 Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-06-302025-03-312024-12-31
Dividends Paid(CNY 47M)(CNY 46M)(CNY 46M)(CNY 41M)(CNY 43M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3759 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 27.1BCNY 23.9BCNY 26.5BCNY 20.5B—
Total LiabilitiesCNY 11.4BCNY 9.7BCNY 13.2BCNY 9.7B—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3759 viewer.

Other Companies in Biotechnology

← 3758All “0-9” companies3760 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.